Position in ABBV
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$12,582
+$1,708 QoQ
Shares Held
50
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#4,121
of 4,153 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financial Avengers, Inc. holds $17,063,900 across 8 Drug Manufacturers - General names. ABBV ranks #6 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
47,625 | $12,095,321 | |
| 2 | PFE |
Pfizer Inc
|
131,989 | $3,178,294 | |
| 3 | LLY |
ELI LILLY & Co
|
1,313 | $1,574,851 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,344 | $169,800 | |
| 5 | MRK |
Merck & Co., Inc.
|
132 | $16,962 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
50 | $12,582 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
141 | $8,124 | |
| 8 | AMGN |
Amgen Inc
|
22 | $7,966 |
All Filings in ABBV
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,582 | 50 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $10,874 | 50 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $11,424 | 50 | Shares | Sole | 2026-03-04 | |
| 2025-09-30 | $11,345 | 49 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $9,095 | 49 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $10,056 | 48 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,529 | 48 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $34,953 | 177 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $30,359 | 177 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,558 | 47 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $7,128 | 46 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $6,856 | 46 | Shares | Sole | 2023-11-15 | |
| No filing history on record for this holder in this stock. | ||||||